A newly developed tool—called the PRECISE-DAPT score—enables the identification of patients who have a high risk of out-of-hospital bleeding in the year after PCI, potentially easing individualized ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Reflecting the wide range of current opinions on dual antiplatelet therapy after MI or coronary artery ...

Please provide your email address to receive an email when new articles are posted on . Duration of dual antiplatelet therapy was associated with rates of MI and major bleeding in patients undergoing ...

October 21, 2011 (Atlanta, Georgia) — An analysis of patients treated with the zotarolimus-eluting stent (Endeavor, Medtronic) suggests there is no increased risk of death, myocardial infarction, ...

Trials and subanalyses of shorter dual antiplatelet therapy (DAPT) duration following PCI continue to trickle in from the major cardiology meetings—today’s from TCT 2021—amid growing consensus that ...

Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy (DAPT) did not increase myocardial infarction (MI) or stent thrombosis (ST) in high bleeding risk (HBR) ...

Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However ...

NEW YORK, NY - March 13, 2015 - Data from a meta-analysis published today in The Lancet found that extended duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was ...

The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal, and on the ESC website. The document was developed in ...

The investigators of PRECISE-DAPT devised a five-item score to predict out-of-hospital bleeding risk in patients treated with dual antiplatelet therapy (DAPT) after coronary stenting. In patients at ...

Dual antiplatelet therapy is the cornerstone of treatment after drug-eluting stent implantation. Although treatment for 12 months is the standard of care in many parts of the world, the optimal ...

UPPSALA, SWEDEN — Rates of all-cause death, stroke, or reinfarction among patients discharged from the hospital following revascularization for ACS are lowest among patients taking dual antiplatelet ...